Device Trial Radar · NCT02511678
Multicenter Study of Cryoablation for Palliation of Painful Bone Metastases
Last checked: Nov 19, 2026Latest source record: Jul 19, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
73
Actual
Start
Feb 15, 2016
Primary completion
Mar 12, 2018
Study completion Mar 12, 2018
Sponsor
- Lead sponsor
- Boston Scientific CorporationPublic (BSX)
- Sponsor type
- Industry
- First posted
- Jul 30, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the efficacy of cryoablation for palliation of painful metastases in participants with metastatic lesions involving bone who have failed, are not candidates for, or are not experiencing adequate pain relief from current pain therapies (for example, radiation, analgesics).
Conditions
- Pain
- Neoplasm Metastasis
- Bone Metastasis of Diverse Origins
Interventions
CryoablationDevice
The application of repeated freeze and thaw cycles to the identified tissues.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Worst Pain Scores as Assessed by the Brief Pain Inventory-Short Form (BPI-SF) at Week 8Time frame: Baseline, Week 8
Locations
11 sites in 2 countries. Site status is shown where the registry gives one.
UCLA Ronald Reagan Medical Center
Los Angeles, California
Emory University Hospital
Atlanta, Georgia
Massachusetts General Hospital
Boston, Massachusetts
8 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.